Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

Phase 4

Terminated

Conditions: Rheumatoid Arthritis

Interventions: Drug: Adalimumab
Drug: Etanercept
Drug: Adalimumab placebo

First Posted Date: 2008-11-24

Last Posted Date: 2012-10-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 13

Registration Number: NCT00796705

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸
Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States
🇺🇸
Feinstein Institute for Medical Research NS-LIJ, Manhassett, New York, United States

and more 13 locations

Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

Recruiting

Conditions: Multiple Sclerosis
Central Nervous System Disease

First Posted Date: 2008-11-20

Last Posted Date: 2025-06-05

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 2400

Registration Number: NCT00794352

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant

Phase 2

Withdrawn

Conditions: Diabetes Mellitus, Type I

Interventions: Drug: Low Molecular Weight Sulfated Dextran
Drug: Heparin
Drug: Mycophenolate Mofetil
Drug: Sirolimus
Drug: Tacrolimus
Drug: Cyclosporine
Drug: Daclizumab
Drug: Basiliximab
Biological: Allogeneic Pancreatic Islet Cells

First Posted Date: 2008-11-13

Last Posted Date: 2014-06-12

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00790439

Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3

Phase 2

Completed

Conditions: Psoriasis
Atopic Dermatitis

Interventions: Drug: Placebo
Drug: Vitamin D3

First Posted Date: 2008-11-13

Last Posted Date: 2017-04-12

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 82

Registration Number: NCT00789880

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸
National Jewish Health, Denver, Colorado, United States

Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection

Recruiting

Conditions: HIV

First Posted Date: 2008-11-11

Last Posted Date: 2025-06-10

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 600

Registration Number: NCT00789009

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation

Phase 2

Completed

Conditions: Diabetes Mellitus, Type I

Interventions: Drug: Low Molecular Weight Sulfated Dextran (LMW-SD)
Drug: Heparin
Drug: CellCept® (Mycophenolate mofetil) OR Rapamune® (Sirolimus)
Drug: Prograf® (Tacrolimus) OR Cyclosporine
Drug: Thymoglobulin® (Anti-thymocyte Globulin) - at first transplant
Drug: Simulect® (Basiliximab) - at 2nd or 3rd transplant
Drug: Klexane® (Enoxaparinsodium)
Drug: Trombyl® or Albyl-E® (Acetylsalicylicacid- ASA)
Drug: Enbrel® (Etanercept)

First Posted Date: 2008-11-11

Last Posted Date: 2021-09-28

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 24

Registration Number: NCT00789308

Locations: 🇳🇴
University Hospital Rikshospitalet, Oslo, Norway
🇸🇪
Karolinska University Hospital, Stockholm, Sweden
🇸🇪
Uppsala University Hospital, Uppsala, Sweden

Hepatitis B and HIV Co-Infection in Patients in Uganda

Completed

Conditions: Hepatitis B
HIV Infections

First Posted Date: 2008-10-31

Last Posted Date: 2019-12-05

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 6303

Registration Number: NCT00782158

Locations: 🇺🇬
International Ctr for Excellence in Research and Rakai Health Sciences Program, Rakai, Uganda
🇺🇬
Infectious Diseases Institute, Kampala, Uganda

Study of Milk Allergy and Tolerance in Children

Phase 2

Completed

Conditions: Food Hypersensitivity
Milk Hypersensitivity

Interventions: Biological: Baked Milk
Biological: Non-baked Milk

First Posted Date: 2008-10-23

Last Posted Date: 2016-03-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 170

Registration Number: NCT00778258

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Vaccine for Prevention of Bird Flu

Phase 1

Completed

Conditions: Influenza, Human

First Posted Date: 2008-10-21

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00776711

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults

Completed

Conditions: Inflammation
Pathologic Processes

First Posted Date: 2008-10-21

Last Posted Date: 2025-06-10

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 310

Registration Number: NCT00776412

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy